Global Nanobiotechnology Market Size, Share, and COVID-19 Impact Analysis, By Therapeutics (Dental Therapies, Cardiac Therapies, Orthopaedic Therapies, and Others), By End-Use (Pharmaceutical, Medical Device, Medical Research, Food & Agriculture, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare

RELEASE DATE Aug 2025
REPORT ID SI14754
PAGES 245
REPORT FORMAT PathSoft

  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Therapeutics
      2. Market Attractiveness Analysis By End Use
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Precision nanomedicine enabled therapies
    3. Restraints
      1.  Regulatory gaps and safety concerns
    4. Opportunities
      1.  AI driven personalized medicine
    5. Challenges
      1. Complex regulatory approval pathways
  6. Global Nanobiotechnology Market Analysis and Projection, By Therapeutics
    1. Segment Overview
    2. Dental Therapies
    3. Cardiac Therapies
    4. Orthopaedic Therapies
  7. Global Nanobiotechnology Market Analysis and Projection, By End-Use
    1. Segment Overview
    2. Pharmaceutical
    3. Medical Device
    4. Medical Research
    5. Food & Agriculture
    6. Others
  8. Global Nanobiotechnology Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Nanobiotechnology Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Nanobiotechnology Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Ablynx
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Nami Therapeutics 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Celgene Corporation 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Nanophase Technologies Corporation 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Sigma Aldrich 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  SkyePharma Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Nanobiotix
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Dabur Pharma
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  2. Global Dental Therapies, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  3. Global Cardiac Therapies, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  4. Global Orthopaedic Therapies, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  5. Global Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  6. Global Pharmaceutical, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  7. Global Medical Device, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  8. Global Medical Research, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  9. Global Food & Agriculture, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  10. Global Others, Nanobiotechnology Market, By Region, 2025-2035(USD Billion)
  11. North America Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  12. North America Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  13. U.S.  Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  14. U.S.  Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  15. Canada Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  16. Canada Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  17. Mexico Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  18. Mexico Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  19. Europe Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  20. Europe Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  21. Germany Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  22. Germany Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  23. France Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  24. France Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  25. U.K.  Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  26. U.K.  Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  27. Italy Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  28. Italy Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  29. Spain Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  30. Spain Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  31. Asia Pacific Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  32. Asia Pacific Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  33. Japan Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  34. Japan Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  35. China Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  36. China Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  37. India Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  38. India Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  39. South America Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  40. South America Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  41. Brazil Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  42. Brazil Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  43. The Middle East and Africa Nanobiotechnology Market, By Therapeutics, 2025-2035(USD   Billion)
  44. The Middle East and Africa Nanobiotechnology Market, By End-Use, 2025-2035(USD   Billion)
  45. UAE Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  46. UAE Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)
  47. South Africa Nanobiotechnology Market, By Therapeutics, 2025-2035(USD Billion)
  48. South Africa Nanobiotechnology Market, By End-Use, 2025-2035(USD Billion)

 

List of Figures 

  1. Global Nanobiotechnology Market Segmentation
  2. Nanobiotechnology Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Nanobiotechnology Market
  9. Top Winning Strategies, 2025-2035
  10. Top Winning Strategies, By Development, 2025-2035(%)
  11. Top Winning Strategies, By Company, 2025-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2025
  18. Market Share Analysis, 2025
  19. Restraint and Drivers:  Nanobiotechnology Market
  20. Nanobiotechnology Market Segmentation, By Therapeutics
  21. Nanobiotechnology Market For Dental Therapies, By Region, 2025-2035 ($ Billion)
  22.  Nanobiotechnology Market For Cardiac Therapies, By Region, 2025-2035 ($ Billion)
  23. Nanobiotechnology Market For Orthopaedic Therapies, By Region, 2025-2035 ($ Billion)
  24.  Nanobiotechnology Market Segmentation, By End-Use
  25.  Nanobiotechnology Market For Pharmaceutical, By Region, 2025-2035 ($ Billion)
  26.  Nanobiotechnology Market For Medical Device, By Region, 2025-2035 ($ Billion)
  27. Nanobiotechnology Market For Medical Research, By Region, 2025-2035 ($ Billion)
  28. Nanobiotechnology Market For Food & Agriculture, By Region, 2025-2035 ($ Billion)
  29. Nanobiotechnology Market For Others, By Region, 2025-2035 ($ Billion)
  30. Ablynx: Net Sales, 2025-2035 ($ Billion)
  31. Ablynx: Revenue Share, By Segment, 2025 (%)
  32. Ablynx: Revenue Share, By Region, 2025 (%)
  33. Nami Therapeutics: Net Sales, 2025-2035 ($ Billion)
  34. Nami Therapeutics: Revenue Share, By Segment, 2025 (%)
  35. Nami Therapeutics: Revenue Share, By Region, 2025 (%)
  36. Celgene Corporation: Net Sales, 2025-2035 ($ Billion)
  37. Celgene Corporation: Revenue Share, By Segment, 2025 (%)
  38. Celgene Corporation: Revenue Share, By Region, 2025 (%)
  39. Nanophase Technologies Corporation: Net Sales, 2025-2035 ($ Billion)
  40. Nanophase Technologies Corporation: Revenue Share, By Segment, 2025 (%)
  41. Nanophase Technologies Corporation: Revenue Share, By Region, 2025 (%)
  42. Sigma-Aldrich: Net Sales, 2025-2035 ($ Billion)
  43. Sigma-Aldrich: Revenue Share, By Segment, 2025 (%)
  44. Sigma-Aldrich: Revenue Share, By Region, 2025 (%)
  45. SkyePharma Pharmaceuticals: Net Sales, 2025-2035 ($ Billion)
  46. SkyePharma Pharmaceuticals: Revenue Share, By Segment, 2025 (%)
  47. SkyePharma Pharmaceuticals: Revenue Share, By Region, 2025 (%)
  48. Nanobiotix: Net Sales, 2025-2035 ($ Billion)
  49. Nanobiotix: Revenue Share, By Segment, 2025 (%)
  50. Nanobiotix: Revenue Share, By Region, 2025 (%)
  51. Dabur Pharma: Net Sales, 2025-2035 ($ Billion)
  52. Dabur Pharma: Revenue Share, By Segment, 2025 (%)
  53. Dabur Pharma: Revenue Share, By Region, 2025 (%)
  54. Others.: Net Sales, 2025-2035 ($ Billion)
  55. Others.: Revenue Share, By Segment, 2025 (%)
  56. Others.: Revenue Share, By Region, 2025 (%)

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies